Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia, affecting a significant proportion of the elderly population. AD is characterized by cognitive decline and functional impairments due to pathological hallmarks like amyloid β-peptide (Aβ) plaques...
Saved in:
| Main Authors: | Sahar Balkhi, Anna Di Spirito, Alessandro Poggi, Lorenzo Mortara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/4/264 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
by: Xueyan Liu, et al.
Published: (2025-08-01) -
Delphinidin attenuates cognitive deficits and pathology of Alzheimer’s disease by preventing microglial senescence via AMPK/SIRT1 pathway
by: Ying Liu, et al.
Published: (2025-06-01) -
Liver-specific expression of ANGPTL8 promotes Alzheimer’s disease progression through activating microglial pyroptosis
by: Jiarui Wei, et al.
Published: (2025-07-01) -
Electroacupuncture mitigates cognitive impairments in chronic hypoxia-induced mice by modulating neuroinflammation
by: Fang Wan, et al.
Published: (2025-06-01) -
Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
by: Anna Di Spirito, et al.
Published: (2025-03-01)